Disc Medicine (IRON) Liabilities and Shareholders Equity (2020 - 2026)

Disc Medicine (IRON) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $750.2 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 5.77% year-over-year to $750.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 29.0% YoY) and the FY2025 annual result came in at $806.9 million, up 62.42% from the prior year.
• Liabilities and Shareholders Equity declined to $750.2 million in Q1 2026 per IRON's latest filing, from $806.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $806.9 million in Q4 2025 and bottomed at $106.0 million in Q3 2022.
• The 5-year median for Liabilities and Shareholders Equity is $384.2 million (2023), against an average of $431.4 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity sank 34.37%; it then jumped 255.08% in 2023.
• Tracing IRON's Liabilities and Shareholders Equity over 5 years: stood at $200.2 million in 2022, then jumped by 83.81% to $368.0 million in 2023, then soared by 34.99% to $496.8 million in 2024, then jumped by 62.42% to $806.9 million in 2025, then decreased by 7.02% to $750.2 million in 2026.
• Per Business Quant, the three latest IRON Liabilities and Shareholders Equity figures stand at $750.2 million (Q1 2026), $806.9 million (Q4 2025), and $630.5 million (Q3 2025).

Peer Comparison